journal article text

Additional file 2: of Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

Authors
Publication date
31 May 2019
Publisher
Doi

    Abstract

    Figure S2. CI values of combination treatment of sorafenib with metapristone. (DOCX 216 kb

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/82152...
      Last time updated on 07/08/2019